Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Critical Reviews in Oncogenesis|February 13, 2018
Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor CellsSandra Donnini, Lorenzo Bazzani, Marina Ziche, et al.
Life Sciences|March 31, 2004
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endotheliumSandra Donnini, Lucia Morbidelli, Giulia Taraboletti, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems StudiesValerio Ciccone, Marina Ziche, Andrea Spini, et al.
Biomedicines|January 18, 2020
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in AgeingGinevra Nannelli, Marina Ziche, Sandra Donnini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatinLucia Morbidelli, Sandra Donnini, Francesco Chillemi, et al.
Oncotarget|March 31, 2018
PGE2 mediates EGFR internalization and nuclear translocation <i>via</i> caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cellsLorenzo Bazzani, Sandra Donnini, Antonio Giachetti, et al.
Circulation Research|August 29, 2009
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathwayFederica Finetti, Sandra Donnini, Antonio Giachetti, et al.
Oncotarget|April 19, 2017
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cellsLorenzo Bazzani, Sandra Donnini, Federica Finetti, et al.
Lymphatic Research and Biology|December 22, 2004
Effects of substance P on mesenteric lymphatic contractility in the ratSandra Amerini, Marina Ziche, Steven T Greiner, et al.
Ecancermedicalscience|July 31, 2020
Repurposing of drugs for triple negative breast cancer: an overviewAndrea Spini, Sandra Donnini, Pan Pantziarka, et al.
Pageof 10